Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial.
Wilbrink LA, de Coo IF, Doesborg PGG, Mulleners WM, Teernstra OPM, Bartels EC, Burger K, Wille F, van Dongen RTM, Kurt E, Spincemaille GH, Haan J, van Zwet EW, Huygen FJPM, Ferrari MD; ICON study group. Wilbrink LA, et al. Among authors: teernstra opm. Lancet Neurol. 2021 Jul;20(7):515-525. doi: 10.1016/S1474-4422(21)00101-0. Lancet Neurol. 2021. PMID: 34146510 Clinical Trial.
Spinal Cord Stimulation With Additional Peripheral Nerve/Field Stimulation Versus Spinal Cord Stimulation Alone on Back Pain and Quality of Life in Patients With Persistent Spinal Pain Syndrome.
van Heteren EPZ, van Roosendaal BWP, van Gorp EJAA, Bronkhorst EM, Kallewaard JW, Wegener JT, Bürger K, Teernstra OPM, Buschman HPJ, Hamm-Faber TE, Vissers KCP. van Heteren EPZ, et al. Among authors: teernstra opm. Neuromodulation. 2023 Apr;26(3):658-665. doi: 10.1016/j.neurom.2021.11.010. Epub 2022 Jan 26. Neuromodulation. 2023. PMID: 35088732 Clinical Trial.
A prospective open label 2-8 year extension of the randomised controlled ICON trial on the long-term efficacy and safety of occipital nerve stimulation in medically intractable chronic cluster headache.
Brandt RB, Wilbrink LA, de Coo IF, Haan J, Mulleners WM, Huygen FJPM, van Zwet EW, Ferrari MD, Fronczek R; ICON study group. Brandt RB, et al. EBioMedicine. 2023 Dec;98:104895. doi: 10.1016/j.ebiom.2023.104895. Epub 2023 Nov 25. EBioMedicine. 2023. PMID: 38007947 Free PMC article. Clinical Trial.
Safety and technical efficacy of early minimally invasive endoscopy-guided surgery for intracerebral haemorrhage: the Dutch Intracerebral haemorrhage Surgery Trial pilot study.
Sondag L, Schreuder FHBM, Pegge SAH, Coutinho JM, Dippel DWJ, Janssen PM, Vandertop WP, Boogaarts HD, Dammers R, Klijn CJM; Dutch ICH Surgery Trial Study Group, part of the CONTRAST consortium. Sondag L, et al. Acta Neurochir (Wien). 2023 Jun;165(6):1585-1596. doi: 10.1007/s00701-023-05599-2. Epub 2023 Apr 27. Acta Neurochir (Wien). 2023. PMID: 37103585 Free PMC article.
Subcutaneous Stimulation as Add-on Therapy to Spinal Cord Stimulation in Patients With Persistent Spinal Pain Syndrome Significantly Increases the Total Electrical Charge per Second: Aspects on Stimulation Parameters and Energy Requirements of the Implanted Neurostimulators.
van Roosendaal BWP, van Heteren EPZ, van Gorp EJ, Bronkhorst EM, Kallewaard JW, Wegener JT, Burger K, Teernstra OPM, Buschman HPJ, Hamm-Faber T, Vissers KCP. van Roosendaal BWP, et al. Among authors: teernstra opm. Neuromodulation. 2023 Apr;26(3):666-675. doi: 10.1016/j.neurom.2021.12.005. Epub 2022 Mar 10. Neuromodulation. 2023. PMID: 35279384 Free article. Clinical Trial.
19 results